Assessing the effects of therapeutic combinations on SARS-CoV-2 infected patient outcomes: A big data approach.

<h4>Background</h4>The COVID-19 pandemic has demonstrated the need for efficient and comprehensive, simultaneous assessment of multiple combined novel therapies for viral infection across the range of illness severity. Randomized Controlled Trials (RCT) are the gold standard by which efficacy of the...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Hamidreza Moradi, H Timothy Bunnell, Bradley S Price, Maryam Khodaverdi, Michael T Vest, James Z Porterfield, Alfred J Anzalone, Susan L Santangelo, Wesley Kimble, Jeremy Harper, William B Hillegass, Sally L Hodder, National COVID Cohort Collaborative (N3C) Consortium
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Public Library of Science (PLoS) 2023-01-01
סדרה:	PLoS ONE
גישה מקוונת:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0282587&type=printable
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!